REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q2 2018 | $10,000 | -37.5% | 15,000 | 0.0% | 0.00% | -100.0% |
| Q1 2018 | $16,000 | 0.0% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $16,000 | -15.8% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $19,000 | +26.7% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $15,000 | -6.2% | 15,000 | +50.0% | 0.00% | 0.0% |
| Q1 2017 | $16,000 | -27.3% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $22,000 | -33.3% | 10,000 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $33,000 | +13.8% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $29,000 | -68.8% | 10,000 | -6.6% | 0.00% | -66.7% |
| Q4 2015 | $93,000 | – | 10,705 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,039,823 | $26,420,000 | 3.79% |
| Foresite Capital Management II, LLC | 1,750,269 | $11,447,000 | 3.48% |
| ARGONAUT CAPITAL MANAGEMENT CORP | 75,000 | $491,000 | 1.65% |
| Abingworth LLP | 327,350 | $2,138,000 | 1.25% |
| Trellus Management Company, LLC | 100,000 | $654,000 | 0.96% |
| Cormorant Asset Management, LP | 896,522 | $5,863,000 | 0.94% |
| DAFNA Capital Management LLC | 90,000 | $589,000 | 0.58% |
| ORACLE INVESTMENT MANAGEMENT INC | 749,064 | $4,898,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |